Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,688 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 635
Recruiting: 365
Ph III recruiting: 20
Growth YoY: −15.2%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (367)

clinicaltrialsPublishedShowing 551–600 of 1,108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03921073	Study of T-VEC in Locally Advanced Cutaneous Angiosarcoma	terminated	Phase 2	5	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Nov 1, 2022	clinicaltrials
NCT05590572	A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma	not yet recruiting	Phase 1 / Phase 2	148	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	2	Oct 21, 2022